36 results
6-K
EX-1.1
ENLV
Enlivex Therapeutics Ltd
29 May 24
Enlivex Therapeutics Closes up to $15 Million Registered Direct Offering
4:20pm
in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general or specific … of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, individually or in the aggregate, have
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
, an access code and additional information regarding the Meeting from the member of the TASE and after carrying out a secured identification process
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance … Data, and Personal Data and to the protection of such IT Systems, Confidential Data, and Personal Data from unauthorized use, access
6-K
EX-99.1
h8h hczqnsp65
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
ktge6edpdbmp
12 Sep 22
Report of Foreign Private Issuer
8:02am
6-K
EX-99.1
i28dtokh80pht
30 Sep 21
Annual and Extraordinary General Meeting of Shareholders
8:01am
6-K
EX-1.1
z3dsf54qc08q0f
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
6-K
EX-10.1
bw72q5keuhwglng
22 Oct 20
Report of Foreign Private Issuer
8:47am
6-K
pq0u1curts
15 Jun 20
Report of Foreign Private Issuer
6:55am
6-K
EX-99.1
pindz1dml84r 5nq
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
upp7 jo4ai2e
5 Mar 20
Report of Foreign Private Issuer
8:16am
6-K
EX-1.1
qsrk sqiq
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
20-F/A
8ioj86 x5
23 Jan 20
Annual report (foreign) (amended)
4:31pm